SEC Form 4 · accession 0001144204-18-061508
DarioHealth Corp. · DRIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Olivier Roger Jarry
Officer — See Remarks
Period of report
Nov 22, 2018
Accepted (ET)
Nov 26, 2018 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001533998
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 22, 2018 | A | 7,103 | $0.70 | A | 67,354 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $0.795 | Nov 22, 2018 | A | 120,000 | A | — | Nov 22, 2024 | Common Stock | 120,000 | 120,000 | D |
Explanation of responses
- F1The reporting person was awarded such securities in exchange for waiving compensation owed in the amount of $5,000 as well as pursuant to the terms of a Consulting Agreement dated March 1, 2017.
- F2The option was granted on November 22, 2018 and provides for vesting as follows: (i) 40,000 shares of common stock vest on the first anniversary of the date of grant; and (ii) the balance will vest in eight equal quarterly installments following the first anniversary of the grant date, subject to the Reporting Person's continued employment by the company.
Remarks
President and Chief Commercial Officer